Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeACQUISITIONS and MERGERSMedtainer, Inc. Completes Acquisition of Advanced Container Technologies

Medtainer, Inc. Completes Acquisition of Advanced Container Technologies

October 20, 2020

On October 9, 2020, Medtainer, Inc. consummated an exchange agreement with California-based Advanced Container Technologies, Inc. and its shareholders under which these shareholders exchanged their shares in ACT for 50,000,000 shares of Medtainer’s common stock. As a result, ACT has become the wholly-owned subsidiary of Medtainer.

In connection with this transaction, Medtainer, which is a Florida corporation, changed its name to Advanced Container Technologies, Inc., effective October 3, 2020, and its trading symbol to ACTX, effective 20 business days after October 9. On October 8, 2020, the outstanding shares of Medtainer’s common stock were reverse-split on the basis of one new share for every 59 shares outstanding. Medtainer now has 51,001,860 shares outstanding, which are held by 427 shareholders.

On August 6, 2020, ACT and GP Solutions, Inc. (“GP”), of Colton, California, entered into a Distributorship Agreement, under which ACT has the exclusive right to market, sell and distribute GP’s products in the United States and its territories. This agreement has an initial term that expires on December 31, 2025, and is renewable indefinitely as long as ACT meets prescribed sales targets. GP manufactures fully insulated, food-grade shipping containers that are specifically modified to provide an optimal controlled environment for growing a wide range of horticultural and agricultural products in all environments and climates. The containers can be used to grow large amounts products in a small volume and in a short period: for example, according to GP, 4,000 heads of romaine lettuce can be grown in a single container in less than 5 weeks.

Medtainer entered into the exchange agreement because its board of directors believed that the company needed to expand its product base and become profitable. Douglas P. Heldoorn, the chief executive officer of Medtainer and a member of its board of directors, stated: “Our sales have been relatively flat for the past several years and the Company has a history of losses. We are delighted to have acquired ACT and believe that it offers an opportunity to expand our products, enter into a new market and increase shareholder value.”

On October 9, Daniel Salinas, of Broken Arrow Oklahoma and Eric Horton, of San Diego California, were appointed to the board of directors, following the resignations of Russell Ward and Jeffory A. Carlson, and Mr. Carlson was appointed chief financial officer of Medtainer.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy